El dimetilsulfoxido en la amiloidosis.

Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial.

Journal of internal medicine·2013

CD20 antigen imaging with ¹²⁴I-rituximab PET/CT in patients with rheumatoid arthritis.

Human antibodies·2011

Differential influence of p38 mitogen activated protein kinase (MAPK) inhibition on acute phase protein synthesis in human hepatoma cell lines.

Annals of the rheumatic diseases·2005

Effects of RWJ 67657, a p38 mitogen activated protein kinase (MAPK) inhibitor, on the production of inflammatory mediators by rheumatoid synovial fibroblasts.

Annals of the rheumatic diseases·2004

Functional ability, social support, and depression in rheumatoid arthritis.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2004

Diagnostic and therapeutic approach of systemic amyloidosis.

The Netherlands journal of medicine·2004

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Olfactomedin 2 Promotes Atherosclerosis by Eliciting Smooth Muscle Foam Cell Formation.

Arteriosclerosis, thrombosis, and vascular biology·2026

Neutral-cumulenic diazo (X[double bond, length as m-dash]C[double bond, length as m-dash]N2) compounds.

Chemical science·2026

Asymmetric radical type 1,2-aryloxy-phosphinolylation of vinylarenes catalyzed by chiral vanadyl complexes.

Communications chemistry·2026

A Postsynthetic Strategy for Oligonucleotides Containing 2-Fluoro-adenine and Isoguanine Nucleobases.

Organic letters·2026

NO and NO2 reactions with oxygenated peroxy radicals lead to indistinguishable product compositions: computational insights from cyclohexene oxidation in presence of NO x.

Environmental science: atmospheres·2026

Formation of Hydroxylated-Benzoyl-Benzofuranones Following the Exposure of Quercetin and Kaempferol to aNitrite-Containing Acidic Medium.

Molecules (Basel, Switzerland)·2026

Videos de Experimentos Relacionados

El dimetilsulfoxido en la amiloidosis

Videos de Conceptos Relacionados

Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial.

CD20 antigen imaging with ¹²⁴I-rituximab PET/CT in patients with rheumatoid arthritis.

Differential influence of p38 mitogen activated protein kinase (MAPK) inhibition on acute phase protein synthesis in human hepatoma cell lines.

Effects of RWJ 67657, a p38 mitogen activated protein kinase (MAPK) inhibitor, on the production of inflammatory mediators by rheumatoid synovial fibroblasts.

Functional ability, social support, and depression in rheumatoid arthritis.

Diagnostic and therapeutic approach of systemic amyloidosis.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Olfactomedin 2 Promotes Atherosclerosis by Eliciting Smooth Muscle Foam Cell Formation.

Neutral-cumulenic diazo (X[double bond, length as m-dash]C[double bond, length as m-dash]N2) compounds.

Asymmetric radical type 1,2-aryloxy-phosphinolylation of vinylarenes catalyzed by chiral vanadyl complexes.

A Postsynthetic Strategy for Oligonucleotides Containing 2-Fluoro-adenine and Isoguanine Nucleobases.

NO and NO2 reactions with oxygenated peroxy radicals lead to indistinguishable product compositions: computational insights from cyclohexene oxidation in presence of NO x.

Formation of Hydroxylated-Benzoyl-Benzofuranones Following the Exposure of Quercetin and Kaempferol to aNitrite-Containing Acidic Medium.

Videos de Experimentos Relacionados

El dimetilsulfoxido en la amiloidosis

Videos de Conceptos Relacionados

Artículos Relacionados